is a highgrade non-Hodgkin's lymphoma with unique features. By using comparative genomic hybridization and interphase cytogenetics, 26 tumors were analyzed to identify genomic imbalances. Gains of chromosomal material were much more frequent than losses (110 Y 10) and involved chromosomes 9p. 12q. and Xq (31% to 50%). Interestingly, gain of Xq coincided with gain of 9p. Distinct high-level amplifications RIMARY MEDIASTINAL (thymic) B-cell lymphoma is a tumor with clinical, immunologic, and histologic features that, in their combination, are quite unique. It occurs in all age groups but predominates in young ad~1ts.l.~ Typically, it is localized in the anterior mediastinum, and a thymic involvement has been repeatedly shown. Accordingly, it is assumed that this B-cell lymphoma is a primary thymic tum~r .~.~,~ Its local growth is aggressive, frequently involving the lungs, and metastases often occur in other organs such as the liver and kidney. Immunologically, primary mediastinal B-cell lymphoma is found to express B-lineage-specific surface molecules such as CD19 and CD20 and has its Ig genes rearranged,2~3~10"3 but displays severe defects in expres- As yet, little is known about genomic alterations in primary mediastinal B-cell lymphoma, in part due to the fact that this tumor has only recently been recognized as distinct lymphoma subentity. Furthermore, as a rare lymphoma type, it is often difficult to obtain fresh material for the preparation of metaphase chromosomes, and no cell lines have been available to allow genetic analysis of tumor-derived cells. The novel approach of comparative genomic hybridization (CGH)" allows the identification of chromosomal copy number changes without the need to culture fresh tumor cells and to prepare metaphase c~~o~o s o~~s .~"~~ For CGH, the genomic DNA of tumor cells is isolated from tumor material and used as probe for fluorescence in situ hybridization (FISH) to normal metaphase chromosomes. Cohybridization of differently labeled genomic DNA, isolated from normal tissue and visualized by a different fluorochrome, allows the assessment of chromosomal imbalances by comparing the signal intensities from tumor and control DNA probes. Chromosomal gains and losses in the tumor are indicated by the increase or decrease of the ratio of the fluorescence signal intensities, respectively.
RIMARY MEDIASTINAL (thymic) B-cell lymphoma is a tumor with clinical, immunologic, and histologic features that, in their combination, are quite unique. It occurs in all age groups but predominates in young ad~1ts.l.~ Typically, it is localized in the anterior mediastinum, and a thymic involvement has been repeatedly shown. Accordingly, it is assumed that this B-cell lymphoma is a primary thymic tum~r .~.~,~ Its local growth is aggressive, frequently involving the lungs, and metastases often occur in other organs such as the liver and kidney. Immunologically, primary mediastinal B-cell lymphoma is found to express B-lineage-specific surface molecules such as CD19 and CD20 and has its Ig genes rearranged,2~3~10"3 but displays severe defects in expression of Ig constituents and HLA class I and II m o l e~u l e s ?~~~'~"~ Histologically, primary mediastinal B-cell lymphoma varies in cell size from medium to large. The cytoplasm of tumor cells is relatively abundant and pale, which led to the term mediastinal clear cell lymphoma (of B-cell type).3 An inconsistent sclerosing reaction led to other designations such as sclerosing mediastinal (B-cell) l y m p h~m a .~,~.~" The latest proposal for the lymphoma classification lists this tumor as a distinct subtype of diffuse large B-cell lymphoma, namely primary mediastinal (thymic) B-cell lymphoma.I6
As yet, little is known about genomic alterations in primary mediastinal B-cell lymphoma, in part due to the fact that this tumor has only recently been recognized as distinct lymphoma subentity. Furthermore, as a rare lymphoma type, it is often difficult to obtain fresh material for the preparation of metaphase chromosomes, and no cell lines have been available to allow genetic analysis of tumor-derived cells. The novel approach of comparative genomic hybridization (CGH)" allows the identification of chromosomal copy number changes without the need to culture fresh tumor cells and to prepare metaphase c~~o~o s o~~s .~"~~ For CGH, the genomic DNA of tumor cells is isolated from tumor material and used as probe for fluorescence in situ hybridization (FISH) to normal metaphase chromosomes. Cohybridization of differently labeled genomic DNA, isolated from normal tissue and visualized by a different fluorochrome, allows the assessment of chromosomal imbalances by comparing the signal intensities from tumor and control DNA probes. Chromosomal gains and losses in the tumor are indicated by the increase or decrease of the ratio of the fluorescence signal intensities, respectively.
In the present study, 26 primary mediastinal B-cell lymphomas were analyzed by CGH. Based on the chromosomal imbalances that could be identified, a set of tumor cases was selected for further analysis of the genomic alterations applying interphase cytogenetics or Southern blot hybridization.
PATIENTS AND METHODS

Patient samples.
Tumor samples were collected from 26 patients with primary mediastinal B-cell lymphoma between 1985 and 1994. The age at diagnosis ranged from 17 to 73 years (median, 42 years; standard deviation [SDI, 14.95 years). Eighteen patients were men and 8 women. All patients had bulky disease in the mediastinum and samples were obtained from these tumor masses. Diagnosis of the lymphomas was based strictly on the criteria established in the publications crucial for this special tumor t~p e l -~. ' ' . '~.~~ using histologic examination as well as immunophenotyping including expression of CD19, CD20, CD22, Igs, HLA-A, B, C, and HLA-DR. Immediately after surgical removal, tissues were frozen in liquid nitrogen and stored at -80°C. Frozen sections of this material were stained with hematoxylideosin and examined for the content of tumor cells before extraction of DNA or preparation of interphase nuclei for further analysis. Tumor samples were only further considered when they exhibited a portion of at least 50% of tumor cells. CGH. Probe DNA was isolated from tumor tissue pieces and control DNA from placenta or peripheral blood lymphocytes of healthy individuals applying proteinase K digestion. Preparation of metaphase chromosomes and preparation and labeling of probe DNA and CGH was performed as described.2s22 Briefly, 1 pg biotinlabeled tumor DNA, 1 pg of digoxigenin-labeled control DNA, and 80 pg of the Cot-l fraction of human DNA were combined in a 12 pL cocktail and hybridized for 48 hours. After posthybridization washes to a stringency of 0. l X SSC at 42T, probe and control DNA were detected via streptavidin-conjugated fluorescein isothiocyanate (FITC) and antidigoxigenin antibody-conjugated tetramethylrhoda-mine-isothiocyanate (TRITC), respectively. Chromosomes were counterstained with DAPI (4,6-diamino-2-phenylindole).
The acquisition and processing of DAPI, FITC, and TRITC images was performed as described previously, and the ratio of FITCl TRITC fluorescence intensities was calculated along each individual chromosome using a dedicated oftw ware.'^ Ratio values obtained from 6 to 10 metaphase cells were averaged and the resulting profile was plotted next to chromosomal ideograms (see Figs 3 and 4) . The thresholds applied for the detection of chromosomal overrepresentation and underrepresentation were the values of 1.25 and 0.75, respectively, which were previously thoroughly t e~t e d .~~.~~ Heterochromatin blocks including the centromeric regions are known to be critical in CGH analysis.2"2s Accordingly, these regions were not considered and appear shaded on the printout of the ratio profiles. Moreover, chromosomes 19 and the distal part of chromosome 1 p were excluded from CGH evaluation because of the frequent occurrence of false-positive CGH results as shown by interphase in situ hybridization using suitable DNA probes (data not shown; see also the l i t e r a t~r e~~~~~~~~) .
Overrepresentations were considered as high-level amplifications when the fluorescence ratio values exceeded 2.0 or when the FITC fluorescence showed strong focal signals and the corresponding ratio profile was diagnostic for overrepresentation. Assignment of highly amplified sequences to chromosomal bands was performed by comparison of signal intensities and DAPI banding on individual chromosomes. The extension of other imbalanced regions was estimated by the comparison of fluorescence ratio profiles and the corresponding regions in chromosome ideograms.
Analysis of interphase nuclei by FISH. The following DNA probes were used in this study: repetitive probes specific for chromosomes 9 (D9Zl; Oncor, Gaithersburg, MD), 10 (al0RP-8; obtained from H. Willard, Cleveland, OH), and X (pBamX5; obtained from B.A. Hamkalo, Seattle, WA); cos-pl6, a contig of 8 cosmid clones covering 250 kb of the region containing tumor-suppressor gene CDKNZ on 9~2 1~' (kindly supplied by M. Dreyling and S. Bohlander, Chicago, IL); and YAC-Xq28, a contig of three YAC clones (10DB3, 24CH4, and AAB2; kindly provided by U. Rogner and A. Poustka, Heidelberg, Germany) covering about 600 kb on band Xq28. Probe labeling, in situ hybridization, and signal evaluation were performed as described previo~sly.~' From seven tumor samples sufficient material was available to perform an interphase cytogenetic analysis (cases 1, 2, 4, 5, 7, 8, and 19). Suspensions of nuclei were prepared from frozen sections (50-pm thick) and transferred onto poly-L-lysine coated slides according to protocols described." At least 200 nuclei were evaluated from each sample. For each probe the normal range was determined in cells from tonsils of five individuals. The mean value of the percentage of nuclei with more than two signals of a given probe plus three times the standard deviation defined the threshold above which chromosomal gain was diagnosed in the tumor cells.
Southern blot analysis. Southern blot analysis was performed as des~ribed.~' A 777-bp c-re1 specific probe representing exon 6b was generated by polymerase chain reaction (PCR) amplification using c-DNA clone Rc/CMV-c-Rel" as template (kindly provided by P.A. Baeuerle and M. L. Schmitz, Freiburg, Germany). PCR was performed using primer 1 (5'-GGT CTC CTC GGT TCA ATT GGA-3') and primer 2 (5'"lTG CTC ATT TTG CAT ACT GCC-3'), both choosen from the sequence described by Brownell et al.3' The amplified DNA fragment was labeled by random priming using "PdCTP. For control hybridizations, the genomic fragment gMHCl-D, 4.2 kb in length, from the cardiac P-myosin heavy chain gene, MYH7, located on 14q12-ql3 was used.32 The degree of REL amplification was determined by densitometric evaluation of the autoradiograph with hybridization signals from probe and control DNA.
RESULTS
CGH analysis. CGH was performed with 26 different cases of primary mediastinal B-cell lymphoma. The analysis of 1 lymphoma (case 12) is shown in Fig 1 representing the ratio image that indicates chromosomal gains and losses by applying a 4-color look-up table. The results of all tumor cases analyzed are summarized in Fig 2. Chromosomal imbalances were found in 24 of the 26 analyzed tumors. In 21 tumors, two or more chromosomes or chromosomal subregions were aneusomic; in 3 cases, an imbalance of only one chromosome was detected (cases 6, 10, and 23). Among the imbalances found, overrepresentations of whole chromosomes or chromosomal regions occurred much more frequently than underrepresentations (1 10 gains v 10 losses). In 4 cases, high-level amplifications were found (Fig 3) .
The most prominent chromosomal imbalances identified are overrepresentations of segments of chromosomes 2, 9, 12, and X. None of these chromosomes was found to be involved in loss of chromosomes 2, 9, 12, and X. None of these chromosomes was found to be involved in loss of chromosomal material. In 50% (13/26) of the tumors there was a gain of DNA sequences in chromosome 9p. The consensus region of overlap is represented by a distinct highlevel amplification assigned to the distal part of band 9p23 and 9p24 (Fig 3) . In 1 case, only 9q and not 9p was overrepresented, possibly representing a second consensus region of imbalanced material of chromosome 9 (35%).
A high incidence of chromosomal gains was also detected with respect to two regions of the X chromosome: the long arm was overrepresented in 8 cases (3 1 %) with the consensus region Xq23-q28, and the short arm in 7 cases (27%) with the consensus region in Xp11. High-level amplifications were found in one tumor affecting XplI-p21 and Xq22-q28 (Fig 3) . There is an interesting correlation of imbalances of chromosome arms 9p and Xq: in 7 of 8 tumors with additional material of chromosome Xq also chromosome 9p was overrepresented.
Gain of the proximal and distal regions of chromosome 12q, corresponding to chromosomal bands 12q 1 1 -q13 and 12q24, constitutes further recurrent aberrations occurring in 19% and 31% of the investigated cases, respectively. Furthermore, in 7 lymphomas (27%) a gain of material of the short arm of chromosome 2 was detected. Two consensus regions could be distinguished with respect to 2p, 2p24-p25, and 2p14-pl5. Among the 5 tumors (19%) with an overrepresentation of the proximal consensus region, in 2 cases (nos. 7 and 12) a distinct high-level amplification was found (Fig 3) .
Further frequent gains were found within chromosome 7q (approximately 7ql1-q31); chromosomal arms 16p (5 times each), 5p, 8q (consensus region 8q24), and l l q (consensus region approximately llq13); as well as the distal part of 16q, 17p, 20q, and 22q (4 times each). Chromosomal loss was only rarely found involving chromosome 13 (2 times) and chromosomes 3, 4q, 7p, 8p, IOq, 169, and 17p ( 1 time each).
The most prominent recurrent imbalances identified by CGH were further characterized by means of interphase cytogenetics and Southern blot analysis.
For 
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Comparison of interphase analysis and CGH. CGH profiles do not indicate the absolute copy numbers of chromosomal regions, because the ratio value of 1.0 represents the balanced state, ie, the average copy number of chromosomal segments. However, only knowledge of the ploidy of a tumor allows an estimate of absolute copy numbers of individual chromosomal regions by CGH. Assessment of the ploidy of a tumor can be performed by interphase cytogenetic analysis of a chromosome that is balanced according to the CGH profile. Accordingly, interphase analysis with a chromosome enumeration probe for chromosome 10 was performed because, according to CGH, chromosome 10 was found in a balanced state in 24 of 26 cases. From five tumors (cases 1, 4, 5, 7, and 8) in which CGH indicated a balanced state for this chromosome, sufficient material was available for the analysis. In each case, more than 85% of the nuclei exhibited two signals, indicating a near diploid status of these tumors (Fig 4A) .
To identify the copy numbers of specific regions of chromosomes 9 and X on the single-cell level, interphase analysis was performed with the four tumors from which sufficient tissue material was available using enumeration probes as well as probes specific for the overrepresented chromosomal arms 9p and Xq. As indicated in Fig 4B, hybridization of the CDKN2 containing probe set cos-p16 (9~21) and the satellite probe D9Z1 (9q12) confumed the CGH data: three to five signals were detected in a high proportion of cells in which the CGH ratio values exceeded the diagnostic cut-off value, whereas the balanced state was confirmed by two interphase signals in the vast majority of nuclei. Similar results were obtained for the X chromosome using probes for the centromere (pBamX5) and Xq28 (YAC-Xq28). Three or more signals detected in the majority of nuclei using both probes correspond to the overrepresentation of these regions identified by CGH (Fig 4C) . These data confirm the CGH results and, furthermore, indicate that the tumor cell population in cases 1,2,7 and 19 are not homogeneous with regard to the copy number of chromosomes 9p and X.
Arnplijication of the c-re1 proto-oncogene. The highlevel amplification of sequences on chromosome 2p13-pl6 in cases 7 and 12 coincides with the map location of protooncogene ~-r e I .~~. "
Because the v-re1 containing avian reticuloendotheliosis retrovirus REV-T is known to induce fatal lymphomas in birds:5 we tested whether c-re1 is part of the respective amplicons. Therefore, Southern blot analysis of genomic DNA from tumors 7 and 12 was performed using a c-rel-specific probe. The probe detected an 8-kb HindIII fragment3' and a 1.9-kb EcoRI fragment in DNA from normal cells. For internal standardization, a probe for the cardiac P-myosin heavy chain gene MYH7 was hybridized to the same filters. The ratio of the REL-and MYH7-specific signals showed a fivefold to IO-fold increase (Fig 3C) , showing high-level amplification of REL in these tumors.
DISCUSSION
In this study, a characteristic pattern of chromosomal imbalances was found in primary mediastinal B-cell lymphoma Chromosomal gains are by far more fiequent than losses, mostly involving chromosomes 2, 12, X, and 9 in 27% to 50% of the cases. Comparison of the cases with overrepresented regions often allowed narrowing of the relevant region down to the size of a chromosomal band. Based on the concept of activation of a protooncogene by the increase of the gene copy number, ie, by a gene dosis effect, putative pmto-oncogenes can be assumed to occur in such regions. In one chromosomal region, high-
The high incidence of chromosome 9 overrepresentations level amplification of a proto-oncogene was proven by means is characteristic for primary mediastinal B-cell lymphoma: of Southern blot analysis. The candidate regions for containing gains of chromosome 9 were described in a cytogenetic study genes with a possible pathogenetic role in primary mediastinal of non-Hodgkin's lymphomas (NHLs), but at a much lower B-cell lymphoma, suggested by CGH data, are discussed below. frequency of about 3%.'h,'7 Furthermore, CGH analyses of 'I more than 60 B-cell NHLs showed no gain of chromosome 9 material.*' In primary mediastinal B-cell lymphoma, overrepresentation regarding chromosome 9 is most frequent in two subregions, one in 9p and the other in 9q. The consensus region of additional material of 9p is presented by a highlevel amplification on 9p23-24. This chromosomal region coincides with a translocation breakpoint found in malignant lymphomas.'x4" It seems intriguing to speculate that the putative oncogene affected by this translocation is also activated in primary mediastinal B-cell 1ymphoma.Without considering this amplification, other candidate genes within 9p include the MLLT3 gene located in 9p22 and involved in ((9; 1 1) in acute lymphocytic leukemia (ALL) and a sequence homologous to NRAS?' Chromosome band 12q24 was overrepresented in 3 1 % of the cases. Trisomy 12 is commonly found in many types of B-cell lymphoma, especially in lymphocytic lymphoma and B-cell lymphocytic leukemia,"'but the subregion considered to be relevant is 12q 12-q22.4' Candidate genes on chromosome 12q24 that could play a role in malignant Gain of material was found at two different sites of chromosome 2, 2p24-p25 and 2p13-pI6. Oncogenes located in the relevant regions are coding for transforming growth factor a (2~13). N-MYC (2p24), the protein tyrosine kinase ALK involved in translocation t(2;5)(p23-p35) in malignant lymphoma, and REL (2pI 3-p15)?' Because the viral re1 gene contained in avian reticuloendotheliosis virus is known to induce malignant transformation of lymphoid and myeloid cells,'5 REL appeared to be an attractive candidate gene for the tumorigenesis of primary mediastinal B-cell lymphoma. Southern blot analysis proved that the high-level amplification on 2p13-pl6 detected in 2 cases by CGH indeed contained REL sequences. REL was previously found to be involved in human hematopoietic malignancies in 4 other cases, 2 cases of follicular lymphoma in which c-re1 was The function of the c-re1 protein provides further clues suggesting a role in the malignant transformation in primary mediastinal B-cell lymphoma. Re1 proteins are subunits of transcription factor oligomeres, including the NFKB complex, which bind to a consensus sequence present in a class of genes critical for B-cell differentiation, such as the genes for the IgK light chain, class I MHC H-2k and P-microglobulin." The expression of these three genes was shown to be frequently impaired in primary mediastinal B-cell Iymph~ma.'~ This could be due to an abnormal expression of the re1 genes as suggested by the genomic overrepresentation of REL.
Overrepresentations of the X-chromosome were found in about one third of the tumors. A similar frequency of gain of the X chromosome was reported in studies of B-cell NHLs applying chromosome banding?' Thus, this chromosomal imbalance seems to be characteristic but not specific for primary mediastinal B-cell lymphoma.
Remarkably, overrepresentations of Xq are closely linked to gains of 9p (7 of 8 cases). Further studies are required to investigate whether this correlation reflects a synergistic effect of genes located on both chromosomes or results from a mulitstep process in tumor progression with, eg, gain of 9p as an earlier genetic change.
It seems intriguing that three of the most frequently overrepresented regions, distal 2p, 9p, and distal 12q, contain genes of the same family of cytokines, the interferons IFNB3 on 2p23-pter, IFNA and IFNBl on 9~2 1 , and IFNG on 12q24.1. At present, the significance of a copy number gain of members of a lymphokine gene family remains unclear. This finding possibly points to a common mechanism of deregulating cell growth and differentiation in this tumor. 31. Brownell E, Mittereder N. Rice NR: A human re1 protooncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935, 1989 32. Lichter P, Umeda PK, Levin JE, Vosberg H-P: Partial characterization of the human P-myosin heavy chain gene which is expressed in heart and skeletal muscle. Eur J Biochem 160: 419, 1986 33. Brownell E, Fell HP, Tucker PW, Geurts van Kessel AHM, Hagemeijer A, Rice NR: Regional localization of the human c-re1
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